Theriva Biologics, Inc. (TOVX)
0.2496
0.00 (0.00%)
USD |
NYAM |
Sep 02, 13:18
Theriva Biologics Research and Development Expense (Annual) : 8.604M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 8.604M |
| December 31, 2024 | 12.03M |
| December 31, 2023 | 14.31M |
| December 31, 2022 | 11.72M |
| December 31, 2021 | 7.80M |
| December 31, 2020 | 5.131M |
| December 31, 2019 | 11.08M |
| December 31, 2018 | 11.84M |
| December 31, 2017 | 18.78M |
| December 31, 2016 | 29.11M |
| December 31, 2015 | 32.91M |
| December 31, 2014 | 14.49M |
| December 31, 2013 | 6.507M |
| December 31, 2012 | 12.29M |
| December 31, 2011 | 1.64M |
| December 31, 2010 | 1.580M |
| Date | Value |
|---|---|
| December 31, 2009 | 1.204M |
| December 31, 2008 | 4.644M |
| December 31, 2007 | 6.328M |
| December 31, 2006 | 2.666M |
| December 31, 2005 | 0.00 |
| December 31, 2004 | 0.00 |
| December 31, 2003 | 0.00 |
| December 31, 2002 | |
| December 31, 2001 | |
| December 31, 2000 | |
| December 31, 1999 | |
| December 31, 1998 | |
| December 31, 1997 | |
| December 31, 1996 | |
| December 31, 1995 | 4.376M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 93.26M |
| Nkarta, Inc. | 81.24M |
| Unicycive Therapeutics, Inc. | 9.121M |
| OnKure Therapeutics, Inc. | 47.81M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |